Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD - Wikidata - awgldk - TriplyDB

Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD

Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD

http://www.wikidata.org/entity/Q58316980

about

Transient and persistent metabolomic changes in plasma following chronic cigarette smoke exposure in a mouse model Protocol for a human in vivo model of acute cigarette smoke inhalation challenge in smokers with COPD: monitoring the nasal and systemic immune response using a network biology approach Trials and tribulations of 'omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine.Fusion of the (1)H NMR data of serum, urine and exhaled breath condensate in order to discriminate chronic obstructive pulmonary disease and obstructive sleep apnea syndrome Determining the presence of asthma-related molecules and salivary contamination in exhaled breath condensate.Metabolomic similarities between bronchoalveolar lavage fluid and plasma in humans and mice Discrimination of sepsis stage metabolic profiles with an LC/MS-MS-based metabolomics approach Metabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals.LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment.Perioperative dynamics and significance of amino acid profiles in patients with cancer.Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD Smokers Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD.Development of a Standard Reference Material for metabolomics research The discordant method: a novel approach for differential correlation.Tryptophan catabolism in acute exacerbations of chronic obstructive pulmonary disease.Lessons from ECLIPSE: a review of COPD biomarkers.The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis.Biomarkers, the control panel and personalized COPD medicine.Proteomics of endometrial cancer diagnosis, treatment, and prognosis.Amino acid profiles as potential biomarkers for pediatric cancers: a preliminary communication.Mass spectrometry based metabolomics for in vitro systems pharmacology: pitfalls, challenges, and computational solutions.The use of cellular and molecular biomarkers to manage COPD exacerbations.Emerging applications of metabolomics in drug discovery and precision medicine.Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update.The respiratory microbiome of HIV-infected individuals.Serum metabolic profiles reveal the effect of formoterol on cachexia in tumor-bearing mice.Defining COPD-Related Comorbidities, 2004-2014.Metabolic re-patterning in COPD airway smooth muscle cells.New Strategies and Challenges in Lung Proteomics and Metabolomics. An Official American Thoracic Society Workshop Report.A Genome-wide Association Study in Hispanics/Latinos Identifies Novel Signals for Lung Function. The Hispanic Community Health Study/Study of Latinos.Chronic Diseases and Lifestyle Biomarkers Identification by Metabolomics.Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study.Metabolic reprogramming in the pathogenesis of chronic lung diseases including BPD, COPD, and pulmonary fibrosis.A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates.NMR spectroscopy-based metabolomic study of serum in sulfur mustard exposed patients with lung disease.NMR- and GC/MS-based metabolomics of sulfur mustard exposed individuals: a pilot study.Phenotyping of Chronic Obstructive Pulmonary Disease Based on the Integration of Metabolomes and Clinical Characteristics.Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women.

P2860

Q28540580-FEE16444-1EE3-4863-B93B-8CB85958DE52 Q28650506-80CE4216-013D-4214-AEDB-3FE032B3D6DD Q30664694-FA2879A1-E718-4624-AF89-AF41EDE07700 Q31009663-14CBCEF6-2C36-4C52-9D04-62A9C9099354 Q33556311-6D5E4E1D-993F-4B9B-BBD4-926919FA0BF5 Q33894887-B6680F2F-BDA7-47A7-A36C-004EB48F3702 Q34692311-9ADED779-BF3E-4ECB-8C11-4DDBE55E01EE Q34766684-C508E0B8-4705-488A-B36C-6B24734D0F20 Q34855603-3E01ED3D-EB3D-4CE5-B5A0-E97FCE4DA52B Q35096373-C1DF860A-4444-40AB-BBF0-DE7683C2405F Q35870656-22594ED2-A39E-47C4-A449-DAE4DAFC273F Q36297783-E91E085F-4120-478C-B96B-7440723122C9 Q36771699-70F92595-873C-4483-ABDA-A4B136D91DE2 Q37220716-DF3192A7-5FFF-4487-A76C-675CA80C38A8 Q37305948-E34C5094-CFF8-4DDE-89B8-D1A41B447238 Q38169066-8AFEDCF9-4E34-4794-9122-F59F2D8D5F67 Q38268820-9733A32E-3C8C-49AF-BDC7-619835163B60 Q38546748-B4748DB6-FD38-408B-A25B-A80C4E8AD84A Q38626386-77E5A232-F5DD-44ED-82EB-21CE0D00FA6C Q38645050-78838003-BC82-4259-8146-0B1F40109ED8 Q38735196-FFB4ECF6-43FB-4435-A966-64433C4226E2 Q38739067-0D6F3B15-5A93-4CC1-AAEA-2AD50A51B80C Q38769103-F5858022-0684-4965-9F9B-D10CEAF2C142 Q38856893-25A34342-DD89-4F7D-BA39-F8756F090698 Q38878361-6B4087CD-677B-4DD1-98FC-0AE9BD682ACB Q39093151-9C446A22-0736-458F-A8FB-3CF31BBBA27A Q41443181-BA15913A-C147-44EB-8E68-04C81B43748E Q47141550-5EA8F09D-CFB5-4DFF-A32D-A3065D2680F6 Q47203339-24396128-FF2C-48DD-966C-D2A3A35CB49B Q47639018-A5EE5D12-CBDC-42F4-AAB6-24F944BCB09B Q47987782-91D53498-80DF-40DC-891D-9E6F4CB1EE1E Q49717949-5278D225-535A-4AA7-9D54-AD3305F15C28 Q49918024-A8435E12-636B-4CAD-AF9F-F7835724959F Q50058176-419FF603-B05C-4289-9D02-B54426053C76 Q51286006-6A2F0BE2-88E1-4C07-9AE2-8D43559B3991 Q51440079-0DA5BEFC-D5EF-4039-98D2-E459124AF857 Q55232881-FC1BB866-5C05-431C-88E0-0B5189369A64 Q55398526-F7CB28F3-5383-469F-A06E-A98E876C6444

P2860

Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD

http://www.wikidata.org/entity/Q58316980

description

article

@en

im Januar 2012 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2012

@uk

name

Targeted metabolomics identifi ...... ub-classify patients with COPD

@en

Targeted metabolomics identifi ...... ub-classify patients with COPD

@nl

type

label

Targeted metabolomics identifi ...... ub-classify patients with COPD

@en

Targeted metabolomics identifi ...... ub-classify patients with COPD

@nl

prefLabel

Targeted metabolomics identifi ...... ub-classify patients with COPD

@en

Targeted metabolomics identifi ...... ub-classify patients with COPD

@nl

P1433

Q58316980-2BF5CA40-BC05-47E2-98E9-A8DCC4F708E5

P1476

Q58316980-2357D419-24AC-4AF7-91E0-BC4FF9491CB2

P2093

Q58316980-11CEB18F-7B49-4E90-8646-9AA27C35B613

Q58316980-164BBF05-6FF4-40CA-9450-990C51836B97

Q58316980-2018B63D-9477-4D56-9507-0B57BE158AAB

Q58316980-316F853E-8C25-4CDA-A233-07357E496E9F

Q58316980-47B7A599-5EA0-4D85-84B9-CC32042450D5

Q58316980-8D10AF97-6B82-4A6A-B61B-0356E4A8846D

Q58316980-C4FBA41E-F41C-4663-A54F-446DCF165321

Q58316980-CAA8FF53-9DA5-41F2-A5BF-F86FD37F8BFC

Q58316980-E0633DE4-AC38-4F8F-9CC6-6B248BD5ECC5

P2860

Q58316980-21D0ED50-5233-4227-AFB7-D07D27622041

Q58316980-33F137D2-377A-4D8E-ADBE-4AFD8CB1705B

Q58316980-39E76158-AFDC-40AF-9D25-0C5459E99D9A

Q58316980-65B8037F-BB77-4DB0-9CFB-F0622EBEB8B1

Q58316980-7CE9FE4D-E5CE-4D9B-87FE-322F1EC29E4B

Q58316980-800D05D3-2517-4BD7-9CF5-41E7D5EDDACA

Q58316980-9C8EA82E-8760-499A-A4A5-984CB6A5F27B

Q58316980-BE77982D-63AD-44D3-AC76-470BFB68E116

Q58316980-C33FD047-C502-4984-BDE5-04EF3A6B233C

Q58316980-C90CBEFD-2569-4FC6-AE84-4BC991116087

P304

Q58316980-56B8C68D-A8C1-49A6-AD89-C9AF75AEE753

P31

Q58316980-63E4023C-2458-49E7-8E6E-392705DC394A

P356

Q58316980-BE84BD97-F288-4EE5-A5EE-7F01B6529241

P433

Q58316980-18AD3F05-4AFA-4924-856B-A47308FA45A0

P478

Q58316980-8FF0EB00-7F5D-4866-8A07-E1D9758114CB

P50

Q58316980-2350DC74-D1E9-4493-B12A-2069E1B92E30

Q58316980-FEE22C80-077B-4F64-98D0-6808F33678EB

P577

Q58316980-0AE19A9C-6D11-4BF8-A517-12BD63062B8B

P698

Q58316980-7E593E74-2B49-4CEB-92CA-FCD46EEEE158

P921

Q58316980-D60D450D-DBF4-4BB5-9DD4-2CCFBCE18ED5

P356

P1433

Molecular BioSystems

P1476

Targeted metabolomics identifi ...... ub-classify patients with COPD

@en

P2093

Baljit K. Ubhi

http://www.w3.org/2001/XMLSchema#string

David A. Lomas

http://www.w3.org/2001/XMLSchema#string

Duncan Jodrell

http://www.w3.org/2001/XMLSchema#string

Jiyang Dong

http://www.w3.org/2001/XMLSchema#string

John H. Riley

http://www.w3.org/2001/XMLSchema#string

Julian L. Griffin

http://www.w3.org/2001/XMLSchema#string

Kian Kai Cheng

http://www.w3.org/2001/XMLSchema#string

Susan C. Connor

http://www.w3.org/2001/XMLSchema#string

Tobias Janowitz

http://www.w3.org/2001/XMLSchema#string

P2860

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis.

Plasma levels of amino acids and hypermetabolism in patients with chronic obstructive pulmonary disease.

Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function

Characterisation of COPD heterogeneity in the ECLIPSE cohort

Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms.

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

Metabolic profiling as a tool for understanding mechanisms of toxicity.

Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation

Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.

P304

3125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C2MB25194A

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Ruth Tal-Singer

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23051772

http://www.w3.org/2001/XMLSchema#string

P921